This list is based on the watchlists of people on Stock Events who follow KEEL. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is Mavacamten, an orally administered allosteric modulator of cardiac myosin, which is in Phase III clinical trial for the treatment of hypertrophic cardiomyopathy (HCM). The company also develops Danicamtiv, an orally administered small molecule, which completed Phase I and Phase IIa clinical trials on patients with dilated cardiomyopathy. Its preclinical programs include MYK-224, a small molecule program for the treatment of HCM targeting hypercontractility and impaired relaxation; ACT-1 for the treatment of diastolic dysfunction; and LUS-1 for the treatment of diastolic dysfunction. Myokardia, Inc. was founded in 2012 and is headquartered in Brisbane, California. As of November 16, 2020, MyoKardia, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
Show more...
FAQ
What is Keel Infrastructure stock price today?▼
The current price of KEEL is $6.20 USD — it has increased by +9.54% in the past 24 hours. Watch Keel Infrastructure stock price performance more closely on the chart.
What is Keel Infrastructure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Keel Infrastructure stocks are traded under the ticker KEEL.
When is the next Keel Infrastructure earnings date?▼
Keel Infrastructure is going to release the next earnings report on August 17, 2026.
What were Keel Infrastructure earnings last quarter?▼
KEEL earnings for the last quarter are -0.21 USD per share, whereas the estimation was -0.06 USD resulting in a -243.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Keel Infrastructure have?▼
As of June 16, 2026, the company has 170 employees.
In which sector is Keel Infrastructure located?▼
Keel Infrastructure operates in the Finance & Payments sector.
When did Keel Infrastructure complete a stock split?▼
Keel Infrastructure has not had any recent stock splits.
Where is Keel Infrastructure headquartered?▼
Keel Infrastructure is headquartered in New York, Canada.